Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population

被引:9
作者
Wiederkehr, Daniel [1 ]
Ogbonnaya, Augustina [1 ]
Casciano, Roman [1 ]
Makenbaeva, Dinara [2 ]
Mozaffari, Essy [3 ]
Corbelli, John [4 ]
机构
[1] Analyt Int, New York, NY 10018 USA
[2] Bristol Myers Squibb Co, Plainsboro, NJ USA
[3] Sanofi Aventis, Bridgewater, MA USA
[4] PC & SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY USA
关键词
Acute coronary syndrome; Clopidogrel; Myocardial infarction; Stent; PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; ANTIPLATELET THERAPY; PREMATURE DISCONTINUATION; AMERICAN-COLLEGE; ASPIRIN; TICLOPIDINE; CARDIOLOGY; OUTCOMES; REGISTRY;
D O I
10.1185/03007990903156087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate the association between discontinuation of clopidogrel therapy and risk of acute myocardial infarction (AMI) hospitalization or cardiac revascularization in a nationally-representative patient population following hospitalization for an AMI or coronary stent insertion. Research design and methods: This observational cohort study was performed using data on patients from the PharMetrics Anonymous Patient-Centric Database who were hospitalized for an AMI or coronary stent insertion and subsequently treated with clopidogrel. Cox proportional hazard modeling was used to evaluate the association between clopidogrel discontinuation prior to 1 year post-initial AMI hospitalization and the primary endpoint of repeat AMI hospitalization or coronary intervention defined as percutaneous coronary intervention (PCI) with or without stent, or coronary artery bypass graft (CABG). Main outcome measures: The main outcome for this study was AMI hospitalization or coronary intervention defined as PCI with or without stent placement or CABG. Results: A total of 31 835 patients were included in the analyses. Patients were predominantly male and the average patient age was approximately 60 years. After controlling for baseline patient characteristics and follow-up time, discontinuation of clopidogrel was associated with a significantly higher rate of hospitalization for AMI or coronary intervention (HR 1.34, 95% CI 1.22-1.44). Conclusion: Within a population of ACS patients drawn from a database of 85 US health plans, clopidogrel discontinuation within 1 year following hospitalization for AMI or stent placement is associated with an increased risk of AMI hospitalization or coronary intervention. The results of this study should be interpreted within the context of observational research, which does not address cause and effect relationships.
引用
收藏
页码:2327 / 2334
页数:8
相关论文
共 19 条
[1]  
ACC/AHA, 2007, GUID MAN PAT UNST AN
[2]   Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) [J].
Akhter, Nausheen ;
Milford-Beland, Sarah ;
Roe, Matthew T. ;
Piana, Robert N. ;
Kao, John ;
Shroff, Adhir .
AMERICAN HEART JOURNAL, 2009, 157 (01) :141-148
[3]   Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting - The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) [J].
Bertrand, ME ;
Rupprecht, HJ ;
Urban, P ;
Gershlick, AH .
CIRCULATION, 2000, 102 (06) :624-629
[4]   Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting - The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study [J].
Bertrand, ME ;
Legrand, V ;
Boland, J ;
Fleck, E ;
Bonnier, J ;
Emmanuelson, H ;
Vrolix, M ;
Missault, L ;
Chierchia, S ;
Casaccia, M ;
Niccoli, L ;
Oto, A ;
White, C ;
Webb-Peploe, M ;
Van Belle, E ;
McFadden, EP .
CIRCULATION, 1998, 98 (16) :1597-1603
[5]   Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups [J].
Budaj, A ;
Yusuf, S ;
Mehta, SR ;
Fox, KAA ;
Tognoni, G ;
Zhao, F ;
Chrolavicius, S ;
Hunt, D ;
Keltai, M ;
Franzosi, MG .
CIRCULATION, 2002, 106 (13) :1622-1626
[6]  
CORBELLI J, 2008, CLIN IMPACT EARLY CL
[7]   Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation [J].
Eisenstein, Eric L. ;
Anstrom, Kevin J. ;
Kong, David F. ;
Shaw, Linda K. ;
Tuttle, Robert H. ;
Mark, Daniel B. ;
Kramer, Judith M. ;
Harrington, Robert A. ;
Matchar, David B. ;
Kandzari, David E. ;
Peterson, Eric D. ;
Schulman, Kevin A. ;
Califf, Robert M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02) :159-168
[8]   Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents - A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians [J].
Grines, Cindy L. ;
Bonow, Robert O. ;
Casey, Donald E., Jr. ;
Gardner, Timothy J. ;
Lockhart, Peter B. ;
Moliterno, David J. ;
O'Gara, Patrick ;
Whitlow, Patrick .
CIRCULATION, 2007, 115 (06) :813-818
[9]   Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome [J].
Ho, P. Michael ;
Peterson, Eric D. ;
Wang, Li ;
Magid, David J. ;
Fihn, Stephan D. ;
Larsen, Greg C. ;
Jesse, Robert A. ;
Rumsfeld, John S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (05) :532-539
[10]   Inpatient and follow-up cardiology care and mortality for acute coronary syndrome patients in the Veterans Health Administration [J].
Ho, P. Michael ;
Luther, Stacie A. ;
Masoudi, Frederick A. ;
Gupta, Indra ;
Lowy, Elliott ;
Maynard, Charles ;
Sales, Anne E. ;
Peterson, Eric D. ;
Fihn, Stephan D. ;
Runisfeld, John S. .
AMERICAN HEART JOURNAL, 2007, 154 (03) :489-494